![Michael Carrier Profile](https://pbs.twimg.com/profile_images/3462445715/ab597be0d4301a221b1e87aeecfa0bf9_x96.jpeg)
Michael Carrier
@profmikecarrier
Followers
2K
Following
3K
Statuses
6K
Professor at Rutgers Law School specializing in antitrust and IP law. @[email protected]; @mcarrier.bsky.social
Joined March 2013
RT @MarcEdelman: Forthcoming in @FordhamLRev: "Of Labor, Antitrust and Why the Proposed House Settlement Will Not Solve the NCAA's Problem.…
0
6
0
RT @MarcEdelman: So, the #NCAA is again thinking about reducing the time of its football transfer portal without engaging in collective bar…
0
6
0
RT @MarcEdelman: Glad to see heightened antitrust enforcement in sports and sports-adjacent areas. My friend and frequent co-author, @profm…
0
1
0
RT @McCannSportsLaw: Happy birthday to the man who made NIL possible: @Ed_OBannon. Ed fought for college athletes to have the same rights a…
0
6
0
RT @katie_eyer: We're hiring at Rutgers Law School! This position is in our Camden location, just across the river from Philadelphia. Our f…
0
21
0
RT @FanFairness: Fans deserve a better experience than Ticketmaster’s faulty platform. We agree with the DOJ and experts across the country…
0
1
0
RT @PGunigantiAT: One of the better analyses of U.S. v Live Nation / Ticketmaster I’ve seen — assesses the #antitrust complaint thoroughly…
0
1
0
RT @ProMarket_org: In part I of a two-part series, @RutgersLaw's @profmikecarrier outlines the evidence behind the government’s recent laws…
0
1
0
RT @IMAKglobal: 📅Tomorrow at 12PM ET! @realtahiramin, @profmikecarrier, @AlexHMoss and @RSI’s Wayne Brough will discuss patent policy, how…
0
3
0
RT @RSI: 📆 June 25 on the Hill: Balancing Innovation and Accessibility: Reforming Patent Policy for Patient Benefit
0
1
0
@DanWall55 @dougmelamed @Sherman1890 @lutherlowe In response to @dougmelamed's more appropriate question, I am not being paid, nor have I ever been paid, one penny to write about Live Nation-Ticketmaster.
0
0
1
RT @RSI: 📆 June 25 on the Hill: Balancing Innovation and Accessibility: Reforming Patent Policy for Patient Benefit
0
2
0
Glad to see NCAA will stop enforcing transfer rules. @MarcEdelman and I explained why they violate antitrust law:
0
4
6
RT @GlobalDiaBEATes: Is Congress pivoting to more bipartisan ground? There's widespread agreement that pharmaceutical companies have gamed…
0
3
0
Excellent discussion of the harms from product hopping and of bipartisan legislation that could address this.
New from me @Forbes: How drug companies unlawfully stifle generic competition with "product hopping."
0
0
2